ArticleScientific reports2025
Egg albumin enhances kappa (κ)-carrageenan hydrogels for tunable physicochemical, mechanical, and biological performance.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Formulation of a ModifiedACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogels are versatile polymeric materials valued for their crosslinked structures, which mimic the extracellular matrix. Their tunable size, shape, and pore architecture make them attractive for diverse biomedical applications. In this study, we developed a novel biohybrid hydrogel composed of κ-carrageenan and egg albumin. Egg albumin, extracted from fresh egg whites (Gallus gallus domesticus), was quantified using the Bradford assay. Protein molecular masses were characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and confirmed via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Hydrogel scaffolds were fabricated through ionotropic gelation, forming an interpenetrating polymer network of κ-carrageenan and egg albumin, with sodium chloride (NaCl) and potassium chloride (KCl) from phosphate-buffered saline (PBS) serving as crosslinking agents. Fourier-transform infrared spectroscopy (FTIR) was used to assess polymer crosslinking, and scaffold stability was evaluated through swelling behavior, degradation rate, and mechanical strength. Surface morphology analysis revealed a dense, folded network in pure κ-carrageenan hydrogels, whereas egg albumin incorporation yielded smoother surfaces with protein aggregates-features that increase surface heterogeneity and may promote cell adhesion. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays with NIH 3T3 (mouse embryonic fibroblast) cells demonstrated significantly higher cell proliferation on egg albumin-blended hydrogels compared with pure κ-carrageenan on days 1, 4, and 7. These results indicate that egg albumin-copolymerized hydrogels are promising candidates for soft tissue engineering and drug delivery applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.